New ADHD drug shows promise for kids in Late-Stage trial
Symptom relief
Completed
This study tested a new medication called CTx-1301 (dexmethylphenidate) for children and teens aged 6 to 17 with ADHD. The goal was to see if it reduces ADHD symptoms better than a placebo. 103 participants took either the drug or a placebo, and researchers measured changes in AD…
Phase: PHASE3 • Sponsor: Cingulate Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC